Pharma-Louve SRL
2.6 FTEPharma-Louve reported total assets of €1.55m at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Aug 2026), with 2.6 full-time equivalents.
The score of Pharma-Louve shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +38 % Total assets +19 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma-Louve's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Aug 2026
- Year ended 31 Dec 2024filed on 25 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Pharma-Louve's financial analysis
- Solvency69.4%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma-Louve
Pharma-Louve's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0894.160.549
- VAT number
- BE0894160549
- Peppol
- Registered · 0208:0894160549 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Dec 2007
- Registered office
- 7180 Seneffe
- Size
- Micro · 2.6 FTE
- Latest accounts
- 2025 · filed on 24 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma-Louve (SRL) has been based in Seneffe since 2007, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 110,741 € and equity of €1.08m; its revenue is not published. With 2.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 69.4%, above the median of its sector (41.5%).
Companies similar to Pharma-Louve
Companies in the same business, of comparable size and area, outside its group.
- Antophar Retail sale of pharmaceutical products Antoing · balance sheet €1.55m
- Apotheek J. Moonen Retail sale of pharmaceutical products Lille · balance sheet €1.55m
- Mariacor Retail sale of pharmaceutical products Saint-Léger (Lux.) · balance sheet €1.55m
- Lenapharm Pharmacie Retail sale of pharmaceutical products Ixelles · balance sheet €1.56m
- Sophade Retail sale of pharmaceutical products Wavre · balance sheet €1.54m
- Pharmacie Haufroid Retail sale of pharmaceutical products Villers-le-Bouillet · balance sheet €1.56m
- Geassocieerde Apotheek Markgrave Retail sale of pharmaceutical products Antwerp · balance sheet €1.56m
- Apoteek Goossens Retail sale of pharmaceutical products Wemmel · balance sheet €1.56m
Frequently asked questions about Pharma-Louve
What is the revenue of Pharma-Louve?
Pharma-Louve files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma-Louve?
In Belgium, the VAT number is the company number prefixed with BE: BE0894160549 for Pharma-Louve, if the company is VAT-registered. Its company number (CBE) is 0894.160.549.
Where is the registered office of Pharma-Louve?
According to the CBE register, the registered office of Pharma-Louve is in 7180 Seneffe.
What is the equity of Pharma-Louve?
At the close of the 2025 financial year, the equity of Pharma-Louve amounts to 1,075,095 €, a solvency of 69.4% of total assets.
How many people work at Pharma-Louve?
2.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma-Louve?
The register lists 2 active mandates at Pharma-Louve. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma-Louve
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →